Research centers on behavioral genetics and addiction genomics, integrating pharmacogenetics with the microbiome and developmental exposures. Combines diverse mouse populations and clinical cohorts to map genome-to-phenotype links, quantify drug responses, and strengthen genetic quality control and reproducible behavioral phenotyping.